Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Clinical trial NCT07210515 · RECRUITING

Trial details

NCT number: NCT07210515
Sponsor: Ambros Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Complex Regional Pain Syndrome Type I

Start date: 2026-04-14
Primary completion: 2027-12-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.